News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SIRO Clinpharm (India) Announces Appointment of Gopakumar Menon as Chief Executive Officer to Lead the Global Clinical Research Organization


3/8/2012 9:03:58 AM

MUMBAI, India, March 7, 2012 /PRNewswire/ --

SIRO Clinpharm, a leading full service Clinical Research Organization announced the appointment of Gopakumar Menon as Chief Executive Officer. SIRO has developed a long term plan to align with the changing dynamics of the biopharma industry, and his primary charter is to transform SIRO into a global leader in the CRO and FSP space. He will be responsible for continuing to build and enhance the biopharma service catalog for SIRO's global delivery model, across the Americas, Europe and Asia.

"It is a pleasure to have Gopakumar on board. Gopakumar brings with him rich experience in driving business growth, and delivering tremendous value for leading companies, including Fortune 1000 companies," said Dr. Gautam Daftary, Chairman of SIRO Clinpharm. "Gopakumar has an excellent track record in cultivating partnership based relationships with Fortune 500 pharmaceutical client base, envisioning cutting-edge business and technical solutions for clients across U.S., Europe, Japan, India, China and Singapore. His experience and knowledge will help SIRO to enhance its services, and build a strong presence in new markets where the company plans to expand its frontiers."

"The biopharma industry is undergoing significant transformations. Clients are actively seeking quality service providers from the emerging markets, who can understand their specific challenges, and partner to build and deliver innovative solutions in a global delivery model," said Gopakumar. "My first priority will be to leverage decades of experience, tremendous value, and geographic reach of SIRO to make it the partner of choice for business critical services of global biopharma leaders. I look forward to working with Gautam and SIRO's board of directors."

Gopakumar has been with the pharmaceutical industry for the more than 12 years, where he worked in various capacities, from discovery to sales and marketing.

Prior to joining SIRO Clinpharm, Gopakumar was with Boston based Sciformix Inc. Gopakumar has had significant experience working with Fortune 500 companies like Cognizant and Satyam, in their Life Sciences divisions, as well as with venture funded start-up organizations.

About SIRO:

SIRO Clinpharm, winner of Frost & Sullivan Indian Clinical Research Organization of the year 2011 award, is a drug development solutions provider to the global healthcare industry. Our subject expertise gives us an edge in data management, medical writing, biostatistics & clinical trial management. Having a successful track record of 16 years, SIRO works with most top global biopharma & medical device companies. Our therapeutic experience includes but is not limited to oncology, diabetes, cardiology, infectious diseases & respiratory system. We offer flexible business models across service verticals based on client needs.

The company has offices in India, Malaysia, USA, and Israel and in Europe at Germany, Romania, Estonia, Greece, Czech Republic and Spain.

For more information please visit our website- http://www.siroclinpharm.com

Media contact:

Ruchi Sanganeria
Corporate Marketing
Tel: +91-22-2584-8000
ruchi.sanganeria@siroclinpharm.com

SOURCE SIRO Clinpharm


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES